ReviewInternational journal of molecular sciences2022

High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies.

Lavinia Ghiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.